<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(4)</volume><submitter>Zaidan M</submitter><pubmed_abstract>Noninfectious mixed cryoglobulinemic GN (MCGN) has been poorly investigated. We analyzed presentation and outcome of 80 patients with biopsy-proven MCGN, which were identified in the retrospective French CryoVas survey. MCGN was related to primary Sjögren's syndrome in 22.5% of patients and to lymphoproliferative disorders in 28.7% of patients, and was defined as essential in 48.8% of patients. At presentation, hematuria, proteinuria ≥1 g/d, hypertension, and renal failure were observed in 97.4%, 84.8%, 85.3%, and 82.3% of cases, respectively. Mean±eGFR was 39.5±20.4 ml/min per 1.73 m(2) Membranoproliferative GN was the predominant histologic pattern, observed in 89.6% of cases. Renal interstitium inflammatory infiltrates were observed in 50% of cases. First-line treatment consisted of ste</pubmed_abstract><journal>Journal of the American Society of Nephrology : JASN</journal><pagination>1213-24</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4814186</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.</pubmed_title><pmcid>PMC4814186</pmcid><pubmed_authors>Brocheriou I</pubmed_authors><pubmed_authors>Machet MC</pubmed_authors><pubmed_authors>Noel LH</pubmed_authors><pubmed_authors>Aaron L</pubmed_authors><pubmed_authors>Durieu I</pubmed_authors><pubmed_authors>Noel D</pubmed_authors><pubmed_authors>Woehl JM</pubmed_authors><pubmed_authors>Truchetet F</pubmed_authors><pubmed_authors>Hinschberger O</pubmed_authors><pubmed_authors>Liozon E</pubmed_authors><pubmed_authors>Benarous L</pubmed_authors><pubmed_authors>Larroche C</pubmed_authors><pubmed_authors>Quemeneur T</pubmed_authors><pubmed_authors>Bridoux F</pubmed_authors><pubmed_authors>Pozdzik A</pubmed_authors><pubmed_authors>Hot A</pubmed_authors><pubmed_authors>Vanhille P</pubmed_authors><pubmed_authors>Lok C</pubmed_authors><pubmed_authors>Frouget T</pubmed_authors><pubmed_authors>Abad S</pubmed_authors><pubmed_authors>Frances C</pubmed_authors><pubmed_authors>Salles-Thomasson E</pubmed_authors><pubmed_authors>Onno C</pubmed_authors><pubmed_authors>Callard P</pubmed_authors><pubmed_authors>Jourde N</pubmed_authors><pubmed_authors>Karras A</pubmed_authors><pubmed_authors>Pouget-Abadie JF</pubmed_authors><pubmed_authors>Soria P</pubmed_authors><pubmed_authors>Costedoat-Chalumeau N</pubmed_authors><pubmed_authors>Kahn JE</pubmed_authors><pubmed_authors>Maillard H</pubmed_authors><pubmed_authors>Cougoul P</pubmed_authors><pubmed_authors>Huart A</pubmed_authors><pubmed_authors>Pajot C</pubmed_authors><pubmed_authors>Gutnecht J</pubmed_authors><pubmed_authors>Blanchard-Delaunay C</pubmed_authors><pubmed_authors>Jouanneau C</pubmed_authors><pubmed_authors>Sebille G</pubmed_authors><pubmed_authors>Gil H</pubmed_authors><pubmed_authors>Modesto-Segonds A</pubmed_authors><pubmed_authors>Legallicier B</pubmed_authors><pubmed_authors>Saadoun D</pubmed_authors><pubmed_authors>Lazaro E</pubmed_authors><pubmed_authors>Bonnet F</pubmed_authors><pubmed_authors>Duong Van Huyen JP</pubmed_authors><pubmed_authors>Geffray L</pubmed_authors><pubmed_authors>Leger JM</pubmed_authors><pubmed_authors>Combe C</pubmed_authors><pubmed_authors>Combe B</pubmed_authors><pubmed_authors>Cribier B</pubmed_authors><pubmed_authors>Hermine O</pubmed_authors><pubmed_authors>Pagnoux C</pubmed_authors><pubmed_authors>Senet P</pubmed_authors><pubmed_authors>Croue A</pubmed_authors><pubmed_authors>Loustaud-Ratti V</pubmed_authors><pubmed_authors>de Saint-Martin L</pubmed_authors><pubmed_authors>Zenone T</pubmed_authors><pubmed_authors>Guillaudeau A</pubmed_authors><pubmed_authors>Cordonnier C</pubmed_authors><pubmed_authors>Rullier P</pubmed_authors><pubmed_authors>Leblond V</pubmed_authors><pubmed_authors>Kaplanski G</pubmed_authors><pubmed_authors>Kemmeny JL</pubmed_authors><pubmed_authors>Belenotti P</pubmed_authors><pubmed_authors>Cacoub P</pubmed_authors><pubmed_authors>Cathebras P</pubmed_authors><pubmed_authors>Fraisse T</pubmed_authors><pubmed_authors>Rivalan J</pubmed_authors><pubmed_authors>Chiche L</pubmed_authors><pubmed_authors>Rouvier P</pubmed_authors><pubmed_authors>Daniel L</pubmed_authors><pubmed_authors>Defuentes G</pubmed_authors><pubmed_authors>Perceau G</pubmed_authors><pubmed_authors>Francois A</pubmed_authors><pubmed_authors>Francois H</pubmed_authors><pubmed_authors>Matignon M</pubmed_authors><pubmed_authors>Somogyi A</pubmed_authors><pubmed_authors>Augusto JF</pubmed_authors><pubmed_authors>Goujon JM</pubmed_authors><pubmed_authors>Thiercelin-Legrand MF</pubmed_authors><pubmed_authors>Nochy D</pubmed_authors><pubmed_authors>Woehl-Kremer B</pubmed_authors><pubmed_authors>Makdassi R</pubmed_authors><pubmed_authors>Piette AM</pubmed_authors><pubmed_authors>Lacraz A</pubmed_authors><pubmed_authors>Vivet B</pubmed_authors><pubmed_authors>Hummel A</pubmed_authors><pubmed_authors>Ronco P</pubmed_authors><pubmed_authors>Michel C</pubmed_authors><pubmed_authors>Sarrot-Reynauld F</pubmed_authors><pubmed_authors>Meyer O</pubmed_authors><pubmed_authors>Lepreux S</pubmed_authors><pubmed_authors>Launay D</pubmed_authors><pubmed_authors>Le Guenno G</pubmed_authors><pubmed_authors>Weiller PJ</pubmed_authors><pubmed_authors>Onuifarasoaniaina S</pubmed_authors><pubmed_authors>Ly K</pubmed_authors><pubmed_authors>Limal N</pubmed_authors><pubmed_authors>Marie I</pubmed_authors><pubmed_authors>CryoVas study group</pubmed_authors><pubmed_authors>Queyrel V</pubmed_authors><pubmed_authors>Ferlicot S</pubmed_authors><pubmed_authors>Vagneur JP</pubmed_authors><pubmed_authors>Serratrice J</pubmed_authors><pubmed_authors>Evon P</pubmed_authors><pubmed_authors>Hachulla E</pubmed_authors><pubmed_authors>Terrier B</pubmed_authors><pubmed_authors>Schaeverbeke T</pubmed_authors><pubmed_authors>Nove-Josserand R</pubmed_authors><pubmed_authors>Mariette X</pubmed_authors><pubmed_authors>Diot E</pubmed_authors><pubmed_authors>Plaisier E</pubmed_authors><pubmed_authors>Chosidow O</pubmed_authors><pubmed_authors>Seror R</pubmed_authors><pubmed_authors>Dijoud F</pubmed_authors><pubmed_authors>Lambotte O</pubmed_authors><pubmed_authors>Martin A</pubmed_authors><pubmed_authors>Carrat F</pubmed_authors><pubmed_authors>Bakir R</pubmed_authors><pubmed_authors>Blaison G</pubmed_authors><pubmed_authors>Rioux-Leclercq N</pubmed_authors><pubmed_authors>Modiano P</pubmed_authors><pubmed_authors>Verpont MC</pubmed_authors><pubmed_authors>Perlat A</pubmed_authors><pubmed_authors>Doucet L</pubmed_authors><pubmed_authors>Zaidan M</pubmed_authors><pubmed_authors>Desvaux D</pubmed_authors><pubmed_authors>Felix S</pubmed_authors><pubmed_authors>Beneton N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.</name><description>Noninfectious mixed cryoglobulinemic GN (MCGN) has been poorly investigated. We analyzed presentation and outcome of 80 patients with biopsy-proven MCGN, which were identified in the retrospective French CryoVas survey. MCGN was related to primary Sjögren's syndrome in 22.5% of patients and to lymphoproliferative disorders in 28.7% of patients, and was defined as essential in 48.8% of patients. At presentation, hematuria, proteinuria ≥1 g/d, hypertension, and renal failure were observed in 97.4%, 84.8%, 85.3%, and 82.3% of cases, respectively. Mean±eGFR was 39.5±20.4 ml/min per 1.73 m(2) Membranoproliferative GN was the predominant histologic pattern, observed in 89.6% of cases. Renal interstitium inflammatory infiltrates were observed in 50% of cases. First-line treatment consisted of ste</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Apr</publication><modification>2025-04-21T18:39:55.583Z</modification><creation>2019-03-27T03:10:40Z</creation></dates><accession>S-EPMC4814186</accession><cross_references><pubmed>26260165</pubmed><doi>10.1681/asn.2015020114</doi><doi>10.1681/ASN.2015020114</doi></cross_references></HashMap>